Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules
Links shared publicly online about this topic.
- 1,606total visits
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r
View full resource at medicalnewstoday.com
Tags: ADHD, ADHD Medication, Emotional Health, Phase 3 Clinical Trial, Children's Health, Vyvanse, Shire
Most Recently Shared on November 13, 2009 at 1:10 pm By:
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (l.. http://bit.ly/36XeTm
Advertisement
